Parkinson's Disease Stocks List

Parkinson's Disease Stocks Recent News

Date Stock Title
May 3 ANVS Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
May 2 ANVS Annovis Bio: Alzheimer's Disease Topline Data Disappoints The Market
May 2 ANVS Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
May 2 ANVS Impact Of Buntanetap Trial Results On Annovis Bio Stock And Future Prospects
May 2 ANVS Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
May 2 ANVS Annovis Bio: Alzheimer's Phase 2/3 Topline Readout Puts Future For Buntanetap Into Question
May 1 ITCI Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?
Apr 30 ITCI Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast
Apr 30 ATHE Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
Apr 30 PMN ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies
Apr 30 ANVS Annovis Bio: Searching For Efficacy In Alzheimer's Disease
Apr 30 ITCI Intra-Cellular Therapies: Positive MDD Data And Commercial Momentum Make It A Buy
Apr 29 ANVS Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Apr 29 ANVS Annovis Bio Shares Tumble After Drug Candidate Buntanetap for Alzheimer's Misses Efficacy Endpoint in Phase 2/3 Study
Apr 29 ANVS Annovis Bio tumbles 53% on data for Alzheimer's candidate buntanetap
Apr 29 ANVS UPDATE 2-Annovis tumbles as Alzheimer's treatment misses in mid-stage study
Apr 29 ANVS Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
Apr 29 CGTX Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies
Apr 29 ATHE Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
Apr 27 ANVS FOMC Meeting, Jobs Report, And Apple Earnings Headline Big Week
Parkinson's Disease

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur. Dementia becomes common in the advanced stages of the disease. Depression and anxiety are also common, occurring in more than a third of people with PD. Other symptoms include sensory, sleep, and emotional problems. The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome".The cause of Parkinson's disease is generally unknown, but believed to involve both genetic and environmental factors. Those with a family member affected are more likely to get the disease themselves. There is also an increased risk in people exposed to certain pesticides and among those who have had prior head injuries, while there is a reduced risk in tobacco smokers and those who drink coffee or tea. The motor symptoms of the disease result from the death of cells in the substantia nigra, a region of the midbrain. This results in not enough dopamine in these areas. The reason for this cell death is poorly understood, but involves the build-up of proteins into Lewy bodies in the neurons. Diagnosis of typical cases is mainly based on symptoms, with tests such as neuroimaging being used to rule out other diseases.There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonists being used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms. Surgery to place microelectrodes for deep brain stimulation has been used to reduce motor symptoms in severe cases where drugs are ineffective. Evidence for treatments for the non-movement-related symptoms of PD, such as sleep disturbances and emotional problems, is less strong.In 2015, PD affected 6.2 million people and resulted in about 117,400 deaths globally. Parkinson's disease typically occurs in people over the age of 60, of which about one percent are affected. Males are more often affected than females at a ratio of around 3:2. When it is seen in people before the age of 50, it is called young-onset PD. The average life expectancy following diagnosis is between 7 and 14 years. The disease is named after the English doctor James Parkinson, who published the first detailed description in An Essay on the Shaking Palsy, in 1817. Public awareness campaigns include World Parkinson's Day (on the birthday of James Parkinson, 11 April) and the use of a red tulip as the symbol of the disease. People with Parkinson's who have increased the public's awareness of the condition include actor Michael J. Fox, Olympic cyclist Davis Phinney, and late professional boxer Muhammad Ali.

Browse All Tags